TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
ConvaTec ( (GB:CTEC) ) has provided an update.
ConvaTec Group PLC has executed a share buyback, purchasing 439,326 ordinary shares as part of its $300 million buyback program announced in August 2025. This move is part of the company’s strategy to manage its capital structure effectively, impacting its financial positioning by increasing the number of shares held in treasury and potentially influencing shareholder value.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.25 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Spark’s Take on GB:CTEC Stock
According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Outperform.
ConvaTec’s overall stock score is driven primarily by its strong financial performance, characterized by consistent revenue growth and solid profitability. Technical analysis indicates a moderate upward trend, although valuation metrics suggest the stock may be overvalued. The absence of earnings call insights and corporate events limits additional context.
To see Spark’s full report on GB:CTEC stock, click here.
More about ConvaTec
ConvaTec Group PLC operates in the medical products and technologies industry, focusing on providing solutions for advanced wound care, ostomy care, continence and critical care, and infusion care. The company aims to enhance the lives of patients through innovative healthcare solutions.
Average Trading Volume: 8,867,317
Technical Sentiment Signal: Hold
Current Market Cap: £4.64B
See more data about CTEC stock on TipRanks’ Stock Analysis page.